Webcasts


All series


All Webcasts

Trends in Peptides and Oligonucleotides: Choosing a Partner CDMO

Thursday, September 8, 2022 at 11am EDT; 4pm GMT; 5pm CEST This webinar will highlight the new solubility enhancing Dispersome® technology, which is based on the amorphous stabilization of a given drug using the protein beta-lactoglobulin (BLG) as novel pharmaceutical excipient. Several relevant case studies are presented to showcase the potential of this new technology. Subsequently, the webinar provides a roadmap on how these formulations can be manufactured on a commercial scale. The webinar will also cover the manufacturing of the formulations.

Development and Scalability of ADCs and CGTs

Thursday June 30, 2022 at 11am ET | 10am CT | 8am PT Cell and gene therapy (CGT) and antibody-drug conjugate (ADC) developers and manufacturers discuss factors that could influence organizations to pursue specific biomolecules for development. Pharmaceutical Technology editors interview experts in CGTs and ADCs in this episode of the Drug Digest video series.

Extractables and Leachables: Trends and Future Directions Part II A roundtable discussion

Wednesday, May 25, 2022 at 11am EDT|8am PDT|5pm CEST|4pm BST In the last few years, the issuance of the ISO 10993-18:2020 medical device guidance and several high-profile publications and round robin studies have resulted in the FDA increasing scrutiny of E&L analyses for both drugs and devices. Join our panel of industry experts to discuss these changes and to learn the direction E&L studies may take in the future.

Drug Digest: Emerging Therapies In all Shapes and Sizes

Thursday April 28, 2022 at 11am ET | 10am CT | 8am PT In this new video series, Drug Digest, the Pharmaceutical Technology editors examine the topic of emerging therapies in more detail, covering subjects such as the challenges of scale, the potential benefits of drug delivery innovation, importance of early analytical studies, the evolution of the regulatory landscape, and differences between regional regulatory requirements. Join the editors as they speak with experts from Regulatory Compliance Associates (RCA), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), and others.

Advanced Troubleshooting for Spray Drying of Pharmaceuticals

Thursday, April 21, 2022 at 11am ET | 4pm GMT | 5pm CET This webinar will discuss risk mitigation strategies used to address common challenges during spray dried powder development and give insight into the impact of spray drying on powder properties in terms of manufacturability and downstream processability.

Cut Pharma Maintenance Costs and Improve Asset Efficiency with AI and Advanced Analytics

Tuesday, April, 19, 2022 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Be assured they have the most uptime possible to keep production on track! Register for this webinar to learn how advanced technologies can help ensure complete asset integrity, guarantee optimal facility conditions (such as temperature, humidity, and vibrations), predict the expected lifespan of equipment and track the energy an asset has consumed and its CO2 emissions.

An Expert Panel Discussion on Best Practices When Transitioning from CSV to CSA

Wednesday, March 23, 2022 at 11am EST | 10am CST | 8am PST The goal of this webinar is to provide clarity on what the upcoming computer software assurance (CSA) guidance means for life sciences companies and what they can do to start preparing. Leading experts from Biogen, Vertex, Alkermes and Verista will share their advice and best practices to ensure a successful rollout.

Capsule formulations to improve delivery of poorly absorbable drugs

Wednesday March 2, 2022 at 11am EST | 4pm GMT | 5pm CET Compounds that are poorly soluble in water are still prevalent in the pharmaceutical industry drug development pipeline. Enabling technologies such as lipid-based formulations (LBF) and amorphous solid dispersions (ASDs) can address these bioavailability limitations, enabling the creation of effective drug products.

Utilizing the GPEx® suite of technologies for cell line development and biomanufacturing of difficult-to-express proteins

Wednesday, February 23rd 2022 at 11am EST | 5pm CET | Molecules with solubility challenges continue to dominate drug development pipelines, increasing the demand for formulation technologies that can solve these issues. Join CMC Consultant, Peter Timmins, Lonza’s Sr. Research Fellow, David Lyon, and Quotient Sciences’ CSO, Peter Scholes, as they outline how a variety of data-driven strategies and integrated program designs can simplify development processes and reduce costs. Using expert insight and case studies they will showcase how spray drying can solve solubility challenges, and demonstrate how integrating GMP manufacturing and clinical testing can rapidly accelerate development timelines.

Wednesday, February 8th at 11am EST | 10am CST | 8am PST Industry shifts in container closure integrity (CCI) are driving the next generation of quality control solutions. Understanding the physics behind the technologies and their relation to your application will carve a path of successful CCI assurance.

Dosage Form Design & Patient Compliance: Exploring ODTs as a Patient-centric Solutions

Thursday, January 27th 2022 at 11AM EST | 4PM GMT | 8AM PST In this webinar, experts provide an overview of the needs of different patient populations, and examine the common challenges leading to non-compliance. The experts also discuss how an orally dissolving tablet (ODT) provides a solution to address patient challenges and enables potentially more successful treatments.

Drug Digest Episode 1 - Pairing the Right APIs and Excipients for Optimizing Formulations

Thursday January 27, 2022 at 11am EST | 10am CST | 8am PST In this new video series, Drug Digest, the Pharmaceutical Technology editors dive into APIs, excipients, and formulation advances, with a focus on pairing the right APIs and excipients for optimizing formulations and efficacy. Join the editors as they speak with experts from Bristol-Myers Squibb, BASF, Thermo Fisher Scientific, Wavelength Pharmaceuticals, and more to determine the most significant factors impacting API and excipient selection as well as the best modalities/drug product forms.

Utilizing the GPEx® suite of technologies for cell line development and biomanufacturing of difficult-to-express proteins

On Demand Webcast Nanoparticles have unique properties that are manipulated to create novel solutions, such as innovative drug delivery systems seen in today’s Covid-19 mRNA vaccines. This webinar explores the analytical techniques used for nanoparticle characterization and its growing significance in drug delivery systems.